These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
155 related items for PubMed ID: 21620115
1. Presence of pituitary adenylate cyclase activating polypeptide and its type I receptor in the rat kidney. Brubel R, Horvath G, Reglodi D, Lubics A, Tamas A, Kiss P, Laszlo E, Nemeth J, Mark L, Szakaly P. Transplant Proc; 2011 May; 43(4):1297-9. PubMed ID: 21620115 [Abstract] [Full Text] [Related]
2. The presence and distribution of pituitary adenylate cyclase activating polypeptide and its receptor in the snail Helix pomatia. Hernádi L, Pirger Z, Kiss T, Németh J, Mark L, Kiss P, Tamas A, Lubics A, Toth G, Shioda S, Reglodi D. Neuroscience; 2008 Aug 13; 155(2):387-402. PubMed ID: 18590802 [Abstract] [Full Text] [Related]
3. Pituitary adenylate cyclase-activating polypeptide and PACAP receptor expression and function in the rat adrenal gland. Mazzocchi G, Malendowicz LK, Neri G, Andreis PG, Ziolkowska A, Gottardo L, Nowak KW, Nussdorfer GG. Int J Mol Med; 2002 Mar 13; 9(3):233-43. PubMed ID: 11836629 [Abstract] [Full Text] [Related]
4. Expression localisation and functional activity of pituitary adenylate cyclase-activating polypeptide, vasoactive intestinal polypeptide and their receptors in mouse ovary. Barberi M, Muciaccia B, Morelli MB, Stefanini M, Cecconi S, Canipari R. Reproduction; 2007 Aug 13; 134(2):281-92. PubMed ID: 17660238 [Abstract] [Full Text] [Related]
5. Comparative distribution of pituitary adenylate cyclase-activating polypeptide (PACAP) binding sites and PACAP receptor mRNAs in the rat brain during development. Basille M, Vaudry D, Coulouarn Y, Jegou S, Lihrmann I, Fournier A, Vaudry H, Gonzalez B. J Comp Neurol; 2000 Oct 02; 425(4):495-509. PubMed ID: 10975876 [Abstract] [Full Text] [Related]
6. Mice deficient in pituitary adenylate cyclase activating polypeptide display increased sensitivity to renal oxidative stress in vitro. Horvath G, Mark L, Brubel R, Szakaly P, Racz B, Kiss P, Tamas A, Helyes Z, Lubics A, Hashimoto H, Baba A, Shintani N, Furjes G, Nemeth J, Reglodi D. Neurosci Lett; 2010 Jan 18; 469(1):70-4. PubMed ID: 19932736 [Abstract] [Full Text] [Related]
7. Pituitary adenylate cyclase-activating polypeptide directly modulates the activity of proopiomelanocortin neurons in the rat arcuate nucleus. Mounien L, Bizet P, Boutelet I, Gourcerol G, Fournier A, Vaudry H, Jégou S. Neuroscience; 2006 Nov 17; 143(1):155-63. PubMed ID: 16962718 [Abstract] [Full Text] [Related]
8. Presence of pituitary adenylate cyclase-activating polypeptide (PACAP) in the plasma and milk of ruminant animals. Czegledi L, Tamas A, Borzsei R, Bagoly T, Kiss P, Horvath G, Brubel R, Nemeth J, Szalontai B, Szabadfi K, Javor A, Reglodi D, Helyes Z. Gen Comp Endocrinol; 2011 May 15; 172(1):115-9. PubMed ID: 21185294 [Abstract] [Full Text] [Related]
9. Pituitary adenylyl cyclase-activating polypeptide (PACAP) and its receptor (PAC1-R) in the cochlea: evidence for specific transcript expression of PAC1-R splice variants in rat microdissected cochlear subfractions. Abu-Hamdan MD, Drescher MJ, Ramakrishnan NA, Khan KM, Toma VS, Hatfield JS, Drescher DG. Neuroscience; 2006 Jun 19; 140(1):147-61. PubMed ID: 16626868 [Abstract] [Full Text] [Related]
11. Distribution of vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide receptors (VPAC1, VPAC2, and PAC1 receptor) in the rat brain. Joo KM, Chung YH, Kim MK, Nam RH, Lee BL, Lee KH, Cha CI. J Comp Neurol; 2004 Aug 30; 476(4):388-413. PubMed ID: 15282712 [Abstract] [Full Text] [Related]
13. Novel stable PACAP analogs with potent activity towards the PAC1 receptor. Bourgault S, Vaudry D, Botia B, Couvineau A, Laburthe M, Vaudry H, Fournier A. Peptides; 2008 Jun 30; 29(6):919-32. PubMed ID: 18353507 [Abstract] [Full Text] [Related]
14. Localization and characterization of pituitary adenylate cyclase-activating polypeptide receptors in the human cerebellum during development. Basille M, Cartier D, Vaudry D, Lihrmann I, Fournier A, Freger P, Gallo-Payet N, Vaudry H, Gonzalez B. J Comp Neurol; 2006 Jun 01; 496(4):468-78. PubMed ID: 16572459 [Abstract] [Full Text] [Related]
18. Investigation of pituitary adenylate cyclase activating polypeptide in human gynecological and other biological fluids by using MALDI TOF mass spectrometry. Brubel R, Reglodi D, Jambor E, Koppan M, Varnagy A, Biro Z, Kiss P, Gaal V, Matkovits A, Farkas J, Lubics A, Bodis J, Bay C, Veszpremi B, Tamas A, Nemeth J, Mark L. J Mass Spectrom; 2011 Feb 01; 46(2):189-94. PubMed ID: 21259400 [Abstract] [Full Text] [Related]
19. Pituitary adenylate cyclase-activating peptide/vasoactive intestinal peptide receptors in human normal mammary gland and breast cancer tissue. García-Fernández MO, Collado B, Bodega G, Cortés J, Ruíz-Villaespesa A, Carmena MJ, Prieto JC. Gynecol Endocrinol; 2005 Jun 01; 20(6):327-33. PubMed ID: 16019382 [Abstract] [Full Text] [Related]
20. Pituitary adenylate cyclase-activating polypeptide stimulates renin secretion via activation of PAC1 receptors. Hautmann M, Friis UG, Desch M, Todorov V, Castrop H, Segerer F, Otto C, Schütz G, Schweda F. J Am Soc Nephrol; 2007 Apr 01; 18(4):1150-6. PubMed ID: 17360952 [Abstract] [Full Text] [Related] Page: [Next] [New Search]